List of works - J Pérez Fidalgo

A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors

scientific article published on 21 November 2016

A Phase 1 open-label study to identify a dosing regimen of the pan-AKT inhibitor AZD5363 for evaluation in solid tumors and in PIK3CA-mutated breast and gynecologic cancers.

scientific article published on 24 October 2017

AKT Inhibition in Solid Tumors With AKT1 Mutations

scientific article published on 10 May 2017

An evaluation of the impact of technical bias on the concordance rate between primary and recurrent tumors in breast cancer.

scientific article

Aurora kinase inhibitors: a new class of drugs targeting the regulatory mitotic system.

scientific article published on December 2009

Aurora kinases in ovarian cancer

scientific article published on 01 October 2020

BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a P

scientific article

Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial

scientific article published on 26 April 2018

Clinical implications of routine genomic mutation sequencing in PIK3CA/AKT1 and KRAS/NRAS/BRAF in metastatic breast cancer.

scientific article published on 14 September 2016

Concordance of genomic alterations between primary and recurrent breast cancer.

scientific article

Deregulation of ARID1A, CDH1, cMET and PIK3CA and target-related microRNA expression in gastric cancer

scientific article

Determination of somatic oncogenic mutations linked to target-based therapies using MassARRAY technology

scientific article published on 09 March 2016

EGF-Induced Acetylation of Heterogeneous Nuclear Ribonucleoproteins Is Dependent on KRAS Mutational Status in Colorectal Cancer Cells

scientific article published on 25 June 2015

Emerging EGFR antagonists for breast cancer.

scientific article published on 15 May 2014

Erratum to: Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

scientific article published on 20 September 2017

GEICO1601-ROLANDO: a multicentric single arm Phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer

scientific article published on 10 January 2019

Impact of a mammography screening programme on the breast cancer population of the Region of Valencia (Spain).

scientific article published in November 2008

In the literature: June 2018.

scientific article published on 20 June 2018

Integrating radical local treatment of the primary in the management of stage IV breast cancer. When is the best moment for the resection of the primary tumor?

scientific article published on 05 April 2012

MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation

scientific article

Management of chemotherapy extravasation: ESMO--EONS clinical practice guidelines

scientific article published on 01 December 2012

MicroRNA profile in very young women with breast cancer

scientific article

Molecular biology in breast cancer: intrinsic subtypes and signaling pathways.

scientific article published on 16 December 2011

Molecular biology of gastric cancer

scientific article published on 01 April 2007

Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy

scientific article published on 21 September 2018

Non-Hodgkin's lymphoma in older people: age is not always an adverse prognostic factor.

scientific article

Parotid gland metastasis of a breast cancer

scientific article published on 01 April 2007

Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer

scientific article published on 07 June 2018

Phase I pharmacokinetic/pharmacodynamic study of MLN8237, an investigational, oral, selective aurora a kinase inhibitor, in patients with advanced solid tumors.

scientific article published on 2 July 2012

Primary carcinoid tumour of the pancreas.

scientific article

Primary paraesophageal Ewing's sarcoma: an uncommon case report and literature review.

scientific article published on 14 May 2015

Prospective Real-World Gynaecological Cancer Clinical Registry with Associated Biospecimens: A Collaborative Model to Promote Translational Research between GEICO and the Spanish Biobank Network

scientific article published on 14 April 2022

Quality-of-Life assessment in malignant pleural effusion treated with indwelling pleural catheter: a prospective study.

scientific article published on 12 February 2014

Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

scientific article published on 16 August 2017

Removal of primary tumor improves survival in metastatic breast cancer. Does timing of surgery influence outcomes?

scientific article published on 03 August 2011

Reply to 'Comment on: management of chemotherapy extravasation: ESMO-EONS clinical practice guidelines'

scientific article published on 13 February 2013

Retrospective analysis of the use of G-CSF and its impact on dose response for anthracycline plus taxane-based schedules in early breast cancer

scientific article

Subcutaneous trastuzumab: drug development and current position.

scientific article published on 29 April 2014

Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literature.

scientific article published on 11 August 2015

Treatment of cervical cancer: the importance of a multidisciplinary team approach

scientific article published on 01 July 2011

Zoledronic acid in the treatment of metastatic breast cancer

scientific article published on January 2014

[Embryonal rhabdomyosarcoma of the prostate. Report of a case and review of the literature]

scientific article published on 01 February 2001

[Non-Hodgkin lymphomas with systemic presentation in patients with HIV infection. Clinical and prognostic factors in a series evaluated before the introduction of the highly active antiretroviral therapy (HAART)]

scientific article published on 01 June 2004

List of works by J Pérez Fidalgo

A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors

A Phase 1 open-label study to identify a dosing regimen of the pan-AKT inhibitor AZD5363 for evaluation in solid tumors and in PIK3CA-mutated breast and gynecologic cancers.

AKT Inhibition in Solid Tumors With AKT1 Mutations

An evaluation of the impact of technical bias on the concordance rate between primary and recurrent tumors in breast cancer.

Aurora kinase inhibitors: a new class of drugs targeting the regulatory mitotic system.

Aurora kinases in ovarian cancer

BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a P

Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial

Clinical implications of routine genomic mutation sequencing in PIK3CA/AKT1 and KRAS/NRAS/BRAF in metastatic breast cancer.

Concordance of genomic alterations between primary and recurrent breast cancer.

Deregulation of ARID1A, CDH1, cMET and PIK3CA and target-related microRNA expression in gastric cancer

Determination of somatic oncogenic mutations linked to target-based therapies using MassARRAY technology

EGF-Induced Acetylation of Heterogeneous Nuclear Ribonucleoproteins Is Dependent on KRAS Mutational Status in Colorectal Cancer Cells

Emerging EGFR antagonists for breast cancer.

Erratum to: Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

GEICO1601-ROLANDO: a multicentric single arm Phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer

Impact of a mammography screening programme on the breast cancer population of the Region of Valencia (Spain).

In the literature: June 2018.

Integrating radical local treatment of the primary in the management of stage IV breast cancer. When is the best moment for the resection of the primary tumor?

MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation

Management of chemotherapy extravasation: ESMO--EONS clinical practice guidelines

MicroRNA profile in very young women with breast cancer

Molecular biology in breast cancer: intrinsic subtypes and signaling pathways.

Molecular biology of gastric cancer

Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy

Non-Hodgkin's lymphoma in older people: age is not always an adverse prognostic factor.

Parotid gland metastasis of a breast cancer

Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer

Phase I pharmacokinetic/pharmacodynamic study of MLN8237, an investigational, oral, selective aurora a kinase inhibitor, in patients with advanced solid tumors.

Primary carcinoid tumour of the pancreas.

Primary paraesophageal Ewing's sarcoma: an uncommon case report and literature review.

Prospective Real-World Gynaecological Cancer Clinical Registry with Associated Biospecimens: A Collaborative Model to Promote Translational Research between GEICO and the Spanish Biobank Network

Quality-of-Life assessment in malignant pleural effusion treated with indwelling pleural catheter: a prospective study.

Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

Removal of primary tumor improves survival in metastatic breast cancer. Does timing of surgery influence outcomes?

Reply to 'Comment on: management of chemotherapy extravasation: ESMO-EONS clinical practice guidelines'

Retrospective analysis of the use of G-CSF and its impact on dose response for anthracycline plus taxane-based schedules in early breast cancer

Subcutaneous trastuzumab: drug development and current position.

Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literature.

Treatment of cervical cancer: the importance of a multidisciplinary team approach

Zoledronic acid in the treatment of metastatic breast cancer

[Embryonal rhabdomyosarcoma of the prostate. Report of a case and review of the literature]

[Non-Hodgkin lymphomas with systemic presentation in patients with HIV infection. Clinical and prognostic factors in a series evaluated before the introduction of the highly active antiretroviral therapy (HAART)]